ABSTRACT
Background We explored the underlying mechanisms that may drive Post-tuberculosis (TB) lung disease, a multifactorial, heterogenous, and prevalent disease.
Methods Extensive clinical phenotyping through fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)-computed tomography (CT) scans, pulmonary function testing, and symptom and quality of life questionnaires, was performed on a cohort of 48 adults who completed TB treatment within 6 months prior. Immunological characteristics of paired blood- and bronchoalveolar lavage fluid (BALF)-derived immune cells were assessed by multiplex bead-based immunoassay, ELISA and flow cytometry.
Results There was agreement between measures of inflammation on PET, the severity of anatomical abnormalities on CT, and pulmonary function testing. However, of these, only PET was associated with exercise tolerance and symptom scores. Measures of radiologic extent (total glycolytic activity and SUVmax on PET, and segments involved on CT) also correlated with proteins detected in blood that implicate Type 1 (IFN-γ, TNFα, IL-12) and Type 2 (IL-4, IL-33) responses, ongoing remodelling of lung tissue (MMPs), airways and vasculature (VEGF), as well as subsets of activated CD8+ and CD4+ T-cells.
Conclusion The radiologic extent of structural post-TB lung involvement is associated with a range of impaired lung function measures and immunological dysregulation. Our findings suggest that obstructive and restrictive lung pathology due to pulmonary tuberculosis do not occur in opposition but rather point towards a mixed pathology in most TB survivors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
We thank CRDF for funding support through grant number: This publication is based on work supported by a grant (G-202212-69613) from the U.S. Civilian Research & Development Foundation (CRDF Global)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was performed in accordance with the Declaration of Helsinki. This human study was approved by the Stellenbosch University Health Research Ethics Committee - approval: N22/11/135 and by the University of Cape Town Human Research Ethics Committee - approval: 004/2023. All adult participants provided written informed consent to participate in this study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
SUMMARY AT A GLANCE We compared clinical (FDG PET-CT and lung physiology) and immune characteristics (multiplex immune assays and flow cytometry) after curative tuberculosis treatment. Residual lung pathology was present in most TB survivors. We found that destructive, obstructive and fibrotic processes occur simultaneously in individuals, and are correlated to radiological extent of disease, remodelling and immune dysregulation.
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos